Pilot program to provide cheaper GLP-1 via Medicare stokes shortage fears

According to The Guardian, Medicare has launched a pilot program providing weight-loss and diabetes medications for just fifty dollars per month to seniors aged sixty-five and older. The temporary initiative aims to improve access to increasingly popular treatments. However, the move is stoking concerns about potential shortages. Demand for these medications, particularly Ozempic and Wegovy, has already strained supplies. The pilot represents a dramatic price reduction compared to retail costs, which can exceed one thousand dollars per month.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton